Krystal Biotech, Inc. price-consensus-chart | Krystal Biotech, Inc. Quote Krystal Biotech’s shares gained 10.1% over the last three month compared with the S&P 500’s decline of 0.2%.

Krystal Biotech, Inc. (KRYS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Consumers bemoaning the high prices at McDonald's and Wendy's can find cheaper fast food elsewhere—if you know where to look.

Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS) stock, but cautious about paying the going market price of $185.97/share, might benefit from considering selling puts among ...

Currently, Krystal Biotech has a market capitalization of $5.20 billion. Buying $1000 In KRYS: If an investor had bought ...

Krystal Integrated Services Ltd share price was up by 0.75% from the previous closing price of ₹714.85. Who are peers of Krystal Integrated Services Ltd? The peers of Krystal Integrated Services ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Krystal Biotech (KRYS – Research Report). The associated ...

Krystal Biotech has a market capitalization of $5.82 billion. Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $426.51 today based on a price of $ ...

Analyst Ritu Baral from TD Cowen maintained a Buy rating on Krystal Biotech (KRYS – Research Report) and keeping the price target at ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.